Announcement PDF Rights Issue Allotment Pursuant to Shortfall Offer 2 July 2026 www.emunl.com.au info@emunl.com.au U3, 180 Main Street KANGAROO POINT QLD 4169 ASX RELEASE | ASX:EMU ASX Code: EMU ABN: 50 127 291 927 Emu NL (EMU or the Company) advises that it has issued a further 6,120,000 shares pursuant to shortfall applications received in respect of the rights issue first announced by the Company on 25 March 2026. The new shares were issued in addition to the issue of new shares to shareholders following the exercise of their rights, as announced on 22 April 2026, the first set of new shortfall shares advised on 13 May 2026 and the second set of new shortfall shares advised on 3 June 2026. The Company has now issued a total of 119,332,102 new shares pursuant to the rights issue and shortfall applications, raising a total of ~$2,983,303 proceeds before costs. The Company will continue to receive additional shortfall applications via its lead broker Martin Place Securities Pty Ltd and Lazarus Pty Ltd appointed as advisors to the O er. The capital structure of the Company following this allotment is as follows: Listed: Code Number Fully paid ordinary shares* EMU 405,497,648 Partly paid ordinary shares ($0.90 paid, $0.90 unpaid) EMUCA 1,349,586 Unlisted: Partly paid ordinary shares ($0.003 paid; $1.20 unpaid) 1,166,670 Partly paid ordinary shares ($0.001 paid; $0.05 unpaid, no call before 30.7.2028) 1,138,952 Partly paid ordinary shares ($0.0001 paid; $0.0749 unpaid, no call before 30.10.2027) 3,400,000 Options to acquire fully paid ordinary shares, exercisable at $0.10 each, expiry 31.10.2026 33,550,000 Options to acquire fully paid ordinary shares, exercisable at $0.09 each, expiry 31.12.2026 10,579,193 Options to acquire fully paid ordinary shares, exercisable at $0.03 each, expiry 3.1.1.2027 119,332,102 Options to acquire fully paid ordinary shares, exercisable at $0.05 each, expiry 28.9.2030 35,917,078 * Includes 616,667 shares which can be bought back by Emu for nil consideration. P a ge 2 AUTHORISED FOR RELEASE BY THE BOARD For further information, please contact: Doug Grewar MD and Chief Executive Officer info@emunl.com.au Investors can sign into our interactive investor hub and join in on the conversation with Emu NL. https://investorhub.emunl.com.au/auth/signup